News
-
09 April 2020
Coronavirus: Government announces support package for charities
Yesterday the Government pledged £750m to help charities during the coronavirus pandemic.
-
01 April 2020
-
09 March 2020
New treatment approved for women with relapsed ovarian cancer in Scotland
There was positive news for women with relapsed ovarian cancer, with the announcement that a new treatment, rucaparib (also known as Rubraca), will now be available on the NHS in Scotland
-
07 February 2020
-
06 February 2020
-
21 January 2020
-
09 January 2020
-
07 January 2020
-
06 December 2019
-
27 November 2019
"We had lots of laughs and bonded with each other as we walked through the busy roads in London"
On October 18th, Natwest walked the London Marathon Route to raise funds for Ovarian Cancer Action. One member of the team, Adam, shares his experience.
-
13 November 2019
One Cancer Voice: A manifesto for people living with cancer
Ovarian Cancer Action is one of 28 cancer charities launching a joint manifesto on behalf of cancer patients across the UK today
-
29 October 2019
-
29 October 2019
Ovarian Cancer Action launches a campaign for the next generation
Ovarian Cancer Action has launched a campaign to put the disease in the spotlight and keep it there, ensuring it gets the attention and research funding it deserves.
-
11 October 2019
A new treatment option for women with relapsed ovarian cancer
There was positive news today for women with relapsed ovarian cancer, with the announcement that a new treatment, rucaparib (also known as Rubraca), will now be available on the NHS.
-
03 October 2019
Beyoncé’s father reveals family’s BRCA link following his breast cancer diagnosis
This week, Matthew Knowles – father of singers Beyoncé and Solange Knowles – shone a different light on both breast cancer and BRCA when he revealed he was recently diagnosed with breast cancer and carries a mutation in his BRCA2 gene.
-
26 July 2019
Personalised treatment becomes a reality for women with hereditary ovarian cancer
In the news today, PARP inhibitor olapoarib is now available to women with newly diagnosed BRCA-mutated ovarian, fallopian and peritoneal cancer following first-line chemotherapy.
-
22 July 2019
Healthcare professionals call for tighter restrictions on at-home genetic testing kits
Senior doctors have called for stricter regulations around consumer genetic testing kits such as 23andMe and AncestryDNA.
-
12 July 2019
New immunotherapy trial for patients with advanced cancer
Funding has been granted to a study where patients with advanced cancer will test a new therapy called bermekibab, aimed at reducing their symptoms and improving their quality of life.
-
05 July 2019
-
03 July 2019
Obesity as a risk factor for ovarian cancer
Around 7% of ovarian cancer cases are caused by being overweight or obese and 1% of cases are caused by smoking. However, whilst these figures highlight that it is important to lead a healthy lifestyle, they also show that the majority of ovarian cancer cases are unrelated to obesity.
